Schedule 13G ownership disclosure

Precision BioSciences, Inc.

Common stock, par value $0.000005 per share · CUSIP: 74019P207

Event date: 2024-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Novartis Pharma AG

    Shares: 413,581.00 · Class: 5.4%

  • Novartis AG

    Shares: 413,581.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-25-012250
Form type
SCHEDULE 13G/A
Filer
NOVARTIS PHARMA AG
CIK
CIK 1030617
Filed
Feb 12, 2025
Reporting period
Dec 31, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub